|
WO2008125945A2
(en)
|
2007-04-12 |
2008-10-23 |
Pfizer Inc. |
3-amido-pyrrolo [3, 4-c] pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as inhibitors of protein kinase c
|
|
US8318762B2
(en)
|
2008-05-28 |
2012-11-27 |
Pfizer Inc. |
Pyrazolospiroketone acetyl-CoA carboxylase inhibitors
|
|
EP2485727A4
(en)
*
|
2009-10-06 |
2013-05-01 |
Afraxis Inc |
PYRROLOPYRAZOLE FOR THE TREATMENT OF CNS DISEASES
|
|
CU24077B1
(es)
*
|
2009-11-10 |
2015-03-30 |
Pfizer |
DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA
|
|
EP2519517B1
(en)
|
2009-12-29 |
2015-03-25 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8933024B2
(en)
|
2010-06-18 |
2015-01-13 |
Sanofi |
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
HRP20161178T1
(hr)
|
2010-09-30 |
2016-11-04 |
Pfizer Inc. |
N1-PIRAZOLOSPIROKETONSKI INHIBITORI ACETIL-CoA-KARBOKSILAZE
|
|
CA2815169C
(en)
|
2010-10-29 |
2015-10-06 |
Pfizer Inc. |
N1/n2-lactam acetyl-coa carboxylase inhibitors
|
|
EA023168B1
(ru)
|
2011-02-11 |
2016-04-29 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Ингибитор катепсина с
|
|
ME02312B
(me)
|
2011-04-22 |
2016-06-20 |
Pfizer |
DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE
|
|
US8846712B2
(en)
|
2011-09-12 |
2014-09-30 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2755652B1
(en)
*
|
2011-09-16 |
2021-06-02 |
Novartis AG |
N-substituted heterocyclyl carboxamides
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
JP6106685B2
(ja)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
Ｃ−ｊｕｎ−ｎ−末端キナーゼ（ｊｎｋ）の阻害剤
|
|
WO2013167403A1
(en)
|
2012-05-09 |
2013-11-14 |
Sanofi |
Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
|
|
US9758522B2
(en)
|
2012-10-19 |
2017-09-12 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
JP6440625B2
(ja)
|
2012-11-14 |
2018-12-19 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
精神分裂病を処置するための方法および組成物
|
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
AU2014337122B2
(en)
|
2013-10-18 |
2019-01-03 |
Dana-Farber Cancer Institute, Inc. |
Heteroaromatic compounds useful for the treatment of proliferative diseases
|
|
WO2015179847A1
(en)
*
|
2014-05-23 |
2015-11-26 |
Mingsight Pharmaceuticals, Inc. |
Treatment of autoimmune disease
|
|
EP3214086B1
(en)
*
|
2014-10-31 |
2021-09-22 |
Ube Industries, Ltd. |
Substituted dihydropyrrolopyrazole compound
|
|
US20170246166A1
(en)
*
|
2014-11-21 |
2017-08-31 |
Eli Lilly And Company |
1,2-benzothiazole compounds for the treatment of kidney disorders
|
|
JP6854762B2
(ja)
*
|
2014-12-23 |
2021-04-07 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
サイクリン依存性キナーゼ７（ｃｄｋ７）の阻害剤
|
|
AU2016243529B2
(en)
|
2015-03-27 |
2021-03-25 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
KR102588426B1
(ko)
|
2015-06-15 |
2023-10-13 |
유비이 가부시키가이샤 |
치환 디히드로피롤로피라졸 유도체
|
|
JP7028766B2
(ja)
|
2015-09-09 |
2022-03-02 |
ダナ－ファーバー キャンサー インスティテュート， インコーポレイテッド |
サイクリン依存性キナーゼの阻害剤
|
|
SG11201804210XA
(en)
|
2015-11-20 |
2018-06-28 |
Mingsight Pharmaceuticals Inc |
Treatment of autoimmune disease
|
|
CN109715166A
(zh)
|
2016-07-14 |
2019-05-03 |
深圳明赛瑞霖药业有限公司 |
癌症的治疗
|
|
EP3810132A4
(en)
|
2018-06-25 |
2022-06-22 |
Dana-Farber Cancer Institute, Inc. |
TAIRE FAMILY KINASE INHIBITORS AND RELATED USES
|
|
US12304913B2
(en)
|
2018-11-14 |
2025-05-20 |
Ube Industries, Ltd. |
Dihydropyrrolopyrazole derivative
|
|
AU2019413694B2
(en)
|
2018-12-28 |
2025-03-20 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 and uses thereof
|
|
CN119684220A
(zh)
*
|
2024-12-13 |
2025-03-25 |
江苏宝众宝达药业股份有限公司 |
一种(2r,5r)-1,2,5-三甲基哌嗪的制备方法
|